Artificial Intelligence (AI) In Clinical Trials Global Market Opportunities And Strategies To 2032 Including: 1) By Offering: Software; Services 2) By Process: Trial Design; Patient Selection; Site Selection; Patient Monitoring 3) By Application: Oncology

Published Jan 04, 2024

Length 276 Pages

SKU # BRC18402807

Description

Artificial Intelligence (AI) In Clinical Trials Global Market Opportunities And Strategies To 2032Including: 1) By Offering: Software; Services2) By Process: Trial Design; Patient Selection; Site Selection; Patient Monitoring3) By Application: Oncology; Neurological Disease And Condition; Cardiovascular Disease; Metabolic Disease; Infectious Disease; Immunology Disease4) By End-User: Pharmaceutical And Biotechnology Company; Contract Research OrganizationsCovering: Saama Technologies Inc.; Trials.Ai; Innoplexus AG; Deep 6 AI In; Unlearn.AI, Inc.

Artificial Intelligence (AI) In Clinical Trials Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global artificial intelligence (AI) in clinical trials market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and

Description:

Where is the largest and fastest growing market for artificial intelligence (AI) in clinical trials? How does the market relate to the overall economy, demography, and other similar markets? What forces will shape the market going forward? The artificial intelligence (AI) in clinical trials market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider artificial intelligence (AI) in clinical trials market; and compares it with other markets.

The report covers the following chapters.

Introduction and Market Characteristics

Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by offering, by process, by application and by end-user market.

Key Trends

Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.

Macro-Economic Scenario

The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the artificial intelligence (AI) in clinical trials market.

Global Market Size and Growth

Global historic (2017-2022) and forecast (2022-2027, 2032F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional And Country Analysis

Historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison by region and country.

Market Segmentation

Contains the market values (2017-2022) (2022-2027, 2032F) and analysis for each segment by offering, by process, by application and by end-user in the market. Historic (2017-2022) and forecast (2022-2027) and (2027-2032) market values and growth and market share comparison by region market.

Regional Market Size and Growth

Regional market size (2022), historic (2017-2022) and forecast (2022-2027,2032F) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.

Competitive Landscape

Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.

Key Mergers and Acquisitions

Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.

Market Opportunities And Strategies

Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.

Conclusions And Recommendations

This section includes recommendations for artificial intelligence (AI) in clinical trials providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.

Appendix

This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Offering: Software; Services

2) By Process: Trial Design; Patient Selection; Site Selection; Patient Monitoring

3) By Application: Oncology; Neurological Disease And Condition; Cardiovascular Disease; Metabolic Disease; Infectious Disease; Immunology Disease; Other Applications

4) By End-User: Pharmaceutical And Biotechnology Company; Contract Research Organizations; Other End-Users

Companies Mentioned: Saama Technologies Inc.; Trials.Ai; Innoplexus AG; Deep 6 AI In; Unlearn.AI, Inc.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; artificial intelligence (AI) in clinical trials indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1. Executive Summary
2. Table Of Contents
3. List Of Tables
4. List Of Figures
5. Report Structure
6. Market Characteristics: 6.1. General Market Definition; 6.2. Summary; 6.3. Artificial Intelligence (AI) In Clinical Trials Market Definition And Segmentations; 6.4. Market Segmentation By Offering; 6.4.1. Software; 6.4.2. Services; 6.5. Market Segmentation By Process; 6.5.1. Trial Design; 6.5.2. Patient Selection; 6.5.3. Site Selection; 6.5.4. Patient Monitoring; 6.6. Market Segmentation By Application; 6.6.1. Oncology; 6.6.2. Neurological Disease And Condition; 6.6.3. Cardiovascular Disease; 6.6.4. Metabolic Disease; 6.6.5. Infectious Disease; 6.6.6. Immunology Disease; 6.6.7. Other Applications; 6.7. Market Segmentation By End-User; 6.7.1. Pharmaceutical And Biotechnology Company; 6.7.2. Contract Research Organizations; 6.7.3. Other End-Users
7. Major Market Trends: 7.1. Introduction Of Cloud-Based Clinical Trial Platforms To Enable Easy Communication; 7.2. Innovative Product Offerings To Clinical Trials With Advanced Data And Technology Platforms; 7.3. Integration Of Real-World Evidence (RWE) Solutions, Pioneering Patient-Centric Advancements In Clinical Research And Digital Services; 7.4. Strategic Partnerships And Collaborations To Develop New Products; 7.5. Increasing Investments To Expand Digital Patient Engagement Programs
8. Artificial Intelligence (AI) In Clinical Trials Market - Macro Economic Scenario: 8.1. COVID-19 Impact On The Artificial Intelligence (AI) In Clinical Trials Market; 8.2. Impact Of The War In Ukraine On The Artificial Intelligence (AI) In Clinical Trials Market; 8.3. Impact Of High Inflation On The Artificial Intelligence (AI) In Clinical Trials Market
9. Global Market Size and Growth: 9.1. Market Size; 9.2. Historic Market Growth, 2017 – 2022, Value ($ Million); 9.2.1. Market Drivers 2017 – 2022; 9.2.2. Market Restraints 2017 – 2022; 9.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 9.3.1. Market Drivers 2022 – 2027; 9.3.2. Market Restraints 2022 – 2027
10. Global Artificial Intelligence (AI) In Clinical Trials Market Segmentation: 10.1. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 10.2. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 10.3. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 10.4. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
11. Artificial Intelligence (AI) In Clinical Trials Market, Regional and Country Analysis: 11.1. Global Artificial Intelligence (AI) In Clinical Trials Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 11.2. Global Artificial Intelligence (AI) In Clinical Trials Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12. Asia-Pacific Market: 12.1. Summary; 12.1.1. Market Overview; 12.1.2. Region Information; 12.1.3. Market Information; 12.1.4. Background Information; 12.1.5. Government Initiatives; 12.1.6. Regulations; 12.1.7. Regulatory Bodies; 12.1.8. Major Associations; 12.1.9. Taxes Levied; 12.1.10. Corporate Tax Structure; 12.1.11. Investments; 12.1.12. Major Companies; 12.2. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.3. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.4. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.5. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis; 12.6. China Market; 12.7. Summary; 12.7.1. Market Overview; 12.7.2. Country Information; 12.7.3. Market Information; 12.7.4. Background Information; 12.7.5. Government Initiatives; 12.7.6. Regulations; 12.7.7. Regulatory Bodies; 12.7.8. Major Associations; 12.7.9. Taxes Levied; 12.7.10. Corporate Tax Structure; 12.7.11. Investments; 12.7.12. Major Companies; 12.8. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.9. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.10. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.11. India Market; 12.12. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.13. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.14. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.15. Japan Market; 12.16. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.17. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.18. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.19. Australia Market; 12.20. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.21. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.22. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.23. Indonesia Market; 12.24. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.25. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.26. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.27. South Korea Market; 12.28. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.29. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 12.30. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13. Western Europe Market: 13.1. Summary; 13.1.1. Market Overview; 13.1.2. Region Information; 13.1.3. Market Information; 13.1.4. Background Information; 13.1.5. Government Initiatives; 13.1.6. Regulations; 13.1.7. Regulatory Bodies; 13.1.8. Major Associations; 13.1.9. Taxes Levied; 13.1.10. Corporate Tax Structure; 13.1.11. Investments; 13.1.12. Major Companies; 13.2. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.3. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.4. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.5. Western Europe Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis; 13.6. UK Market; 13.7. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.8. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.9. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.10. Germany Market; 13.11. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.12. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.13. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.14. France Market; 13.15. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.16. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.17. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.18. Italy Market; 13.19. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.20. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.21. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.22. Spain Market; 13.23. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.24. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 13.25. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14. Eastern Europe Market: 14.1. Summary; 14.1.1. Market Overview; 14.1.2. Region Information; 14.1.3. Market Information; 14.1.4. Background Information; 14.1.5. Government Initiatives; 14.1.6. Regulations; 14.1.7. Regulatory Bodies; 14.1.8. Major Associations; 14.1.9. Taxes Levied; 14.1.10. Corporate Tax Structure; 14.1.11. Investments; 14.1.12. Major Companies; 14.2. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 14.3. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 14.4. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 14.5. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis; 14.6. Russia Market; 14.7. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 14.8. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 14.9. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15. North America Market: 15.1. Summary; 15.1.1. Market Overview; 15.1.2. Region Information; 15.1.3. Market Information; 15.1.4. Background Information; 15.1.5. Government Initiatives; 15.1.6. Regulations; 15.1.7. Regulatory Bodies; 15.1.8. Major Associations; 15.1.9. Taxes Levied; 15.1.10. Corporate Tax Structure; 15.1.11. Investments; 15.1.12. Major Companies; 15.2. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 15.3. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 15.4. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 15.5. North America Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis; 15.6. USA Market; 15.7. Summary; 15.7.1. Market Overview; 15.7.2. Country Information; 15.7.3. Market Information; 15.7.4. Background Information; 15.7.5. Government Initiatives; 15.7.6. Regulations; 15.7.7. Regulatory Bodies; 15.7.8. Major Associations; 15.7.9. Taxes Levied; 15.7.10. Corporate Tax Structure; 15.7.11. Investments; 15.7.12. Major Companies; 15.8. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 15.9. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 15.10. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 15.11. Canada Market; 15.12. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 15.13. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 15.14. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16. South America Market: 16.1. Summary; 16.1.1. Market Overview; 16.1.2. Region Information; 16.1.3. Market Information; 16.1.4. Background Information; 16.1.5. Government Initiatives; 16.1.6. Regulations; 16.1.7. Regulatory Bodies; 16.1.8. Major Associations; 16.1.9. Taxes Levied; 16.1.10. Corporate Tax Structure; 16.1.11. Investments; 16.1.12. Major Companies; 16.2. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 16.3. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 16.4. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 16.5. South America Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis; 16.6. Brazil Market; 16.7. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 16.8. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 16.9. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
17. Middle East Market: 17.1. Summary; 17.1.1. Market Overview; 17.1.2. Region Information; 17.1.3. Market Information; 17.1.4. Background Information; 17.1.5. Government Initiatives; 17.1.6. Regulations; 17.1.7. Regulatory Bodies; 17.1.8. Major Associations; 17.1.9. Taxes Levied; 17.1.10. Corporate Tax Structure; 17.1.11. Investments; 17.1.12. Major Companies; 17.2. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 17.3. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 17.4. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
18. Africa Market: 18.1. Summary; 18.1.1. Market Overview; 18.1.2. Region Information; 18.1.3. Market Information; 18.1.4. Background Information; 18.1.5. Government Initiatives; 18.1.6. Regulations; 18.1.7. Regulatory Bodies; 18.1.8. Major Associations; 18.1.9. Taxes Levied; 18.1.10. Corporate Tax Structure; 18.1.11. Investments; 18.1.12. Major Companies; 18.2. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 18.3. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million); 18.4. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
19. Competitive Landscape and Company Profiles: 19.1. Company Profiles; 19.2. Saama Technologies Inc.; 19.2.1. Company Overview; 19.2.2. Products And Services; 19.2.3. Business Strategy; 19.2.4. Financial Performance; 19.3. Trials.Ai; 19.3.1. Company Overview; 19.3.2. Products And Services; 19.3.3. Financial performance; 19.4. Innoplexus AG; 19.4.1. Company Overview; 19.4.2. Products And Services.; 19.4.3. Business Strategy; 19.4.4. Financial performance; 19.5. Deep 6 AI Inc; 19.5.1. Company Overview; 19.5.2. Products And Services.; 19.5.3. Business Strategy; 19.5.4. Financial performance; 19.6. Unlearn.AI, Inc; 19.6.1. Company Overview; 19.6.2. Products And Services; 19.6.3. Business Strategy; 19.6.4. Financial performance
20. Key Mergers And Acquisitions: 20.1. Recursion Acquired Cyclica and Valence; 20.2. ZS Acquired Trials.ai; 20.3. BioNTech Acquired InstaDeep; 20.4. Beckman Coulter Diagnostics Acquired StoCastic, LLC; 20.5. Bioclinica Acquired Saliency
21. Opportunities And Strategies: 21.1. Global Artificial Intelligence (AI) In Clinical Trials Market In 2027 – Countries Offering Most New Opportunities; 21.2. Global Artificial Intelligence (AI) In Clinical Trials Market In 2027 – Segments Offering Most New Opportunities; 21.3. Global Artificial Intelligence (AI) In Clinical Trials Market In 2027 – Growth Strategies; 21.3.1. Market Trend Based Strategies; 21.3.2. Competitor Strategies
22. Artificial Intelligence (AI) In Clinical Trials Market, Conclusions And Recommendations: 22.1. Conclusions; 22.2. Recommendations; 22.2.1. Product; 22.2.2. Place; 22.2.3. Price; 22.2.4. Promotion; 22.2.5. People
23. Appendix: 23.1. Geographies Covered; 23.2. Market Data Sources; 23.3. Research Methodology; 23.4. Currencies; 23.5. The Business Research Company; 23.6. Copyright and Disclaimer

Pricing

Currency Rates

Single User Online Download $4,000
Global Site License Online Download $8,000

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now